-- 凌宝金鉱業(香港証券取引所:3330)は、既存株の第三者割当増資に続き、新株引受により約7億7060万香港ドルを調達した。これは水曜日に香港証券取引所に提出された書類で明らかになった。 同社の株価は木曜午前の取引で6%以上下落した。 同社は、既存株を同価格で投資家に第三者割当増資した後、売主であるジェシ工業開発(香港)に対し、1株あたり26.16香港ドルで2980万株の新株を発行した。 調達資金は主にセントバーバラ金鉱山プロジェクトの建設、海外買収、中国での鉱物探査、および運転資金に充当される予定だ。 第三者割当増資による新株は、少なくとも6社の投資家に売却されたと同社は述べている。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.